Erik and I wanted to thank our clients, team, friends and families for all the support over the last seven years. Thank you for helping the ROL Group to achieve important milestones.

Our Q3 sales analysis shows a slowing in patent purchases. The first half sales were 139% of 2014 sales, suggesting a big year for sales. Q3 shows a slowdown matching Q3 2014. We have seen Q3 slowdowns before, but this slowdown misses the first half 2015 sales boost. In Q3, we saw 24 sales compared with 25 sales for the same period last year. Q4 will tell us whether the first half of 2015 was an anomaly.

10 Best Practices for Picking a Patent Broker

Asking prices are down, but the patent brokerage business is not in as poor health as it may first appear – especially for a select handful of players. Here, we share our analysis of the brokered patent market in 2015

Targeting the revenues of other companies according to the patent assertion risk they present effectively defines your patent development and external acquisition strategies. We show how to build a financial model to determine where you spend your patent development and buying dollars and then how to calculate risk and ROI.

With the negative press around court decisions against patent holders, you might have heard that the patent market has collapsed/is collapsing. So, is it? In short, no.

ROL Group partners Kent Richardson and Erik Oliver have again been named in the IAM Strategy 300 – The World’s Leading IP Strategists.

At the ROL Group we perform quarterly analysis on patent packages offered for sale on the open market and our 2015 Q1 analysis showed that the number of sales is trending up significantly.

At the ROL Group we carefully track the packages for sale on the brokered patent market in our proprietary database.

The life of a patent broker has never been easy. Over the last year it has become even harder, with prices dropping and deal flow slowing.

The life of a patent broker has never been easy. Over the last year it has become even harder, with prices dropping and deal flow slowing.

IV's new fund bought 16% of all the packages sold in the first half of 2014. As a follow up to our article “What's Inside IV's Patent Portfolio?” we examined Intellectual Venture's recent buying practices, and in particular, buying for their new fund.

When analyzing a large patent portfolio it is often difficult to determine where to spend diligence dollars first. In order to direct us to the specific assets that are more likely to be interesting we developed an in house heuristic ranking system. It is based on static patent characteristics.

In December 2013 Intellectual Ventures (IV) took a step towards transparency by publicly listing about 33,000 of its patent assets, representing 82% of its patent monetization portfolio (http://patents.intven.com/finder). Analyzing IV’s portfolio has now become a tractable problem. Kent Richardson and Erik Oliver penned an article for IAM Magazine that examines what is in the portfolio, what IV buys and what IV did after the purchases.

We are pleased to announce that Kent Richardson, Erik Oliver and Monica Winghart have been selected for inclusion in Intellectual Asset Management Magazine's IAM Strategy 300: The World's Leading IP Strategists.

If you have ever been involved in an opposition or cancellation proceeding before the US Patent and Trademark Office’s Trademark Trial and Appeal Board (USPTO’s TTAB), there probably came a time when you wondered if there was a better, more efficient way to resolve trademark registration disputes.

We look at 186 patent sales packages – consisting of a total of 5,394 issued US patents and 7,595 total patent assets worldwide – offered by brokers and other sellers over the past three years. Analysis includes average asking prices ($344K per asset), time to close is about 180 days, and 16% actually sell.